back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-07-07 12:14 Tx date 2025-06-30 |
$APLI
Appili Therapeutics Inc. |
Froehlich, Juergen
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
1,239,500 | |
| Filed 2025-07-04 12:35 Tx date 2025-06-30 |
$APLI
Appili Therapeutics Inc. |
Froehlich, Juergen
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
||
| Filed 2025-07-04 12:35 Tx date 2025-06-30 |
$APLI
Appili Therapeutics Inc. |
Froehlich, Juergen
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+100,000 vol |
1,239,500 | |
| Filed 2024-05-01 23:38 Tx date 2024-04-29 |
$APLI
Appili Therapeutics Inc. |
Froehlich, Juergen
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$17,680
+442,000 vol $0.04 each |
1,139,500 | |
| Filed 2023-06-01 18:01 Tx date 2023-05-15 |
$APLI
Appili Therapeutics Inc. |
Froehlich, Juergen
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+452,500 vol |
697,500 | |
| Filed 2023-01-12 14:00 Tx date 2023-01-04 |
$APLI
Appili Therapeutics Inc. |
Froehlich, Juergen
4 - Director of Issuer
Direct Ownership
|
Options
38 - Redemption, retraction, cancellation, repurchase
|
$-170,800
-140,000 vol $1.22 each |
245,000 | |
| Filed 2023-01-12 13:59 Tx date 2023-01-04 |
$APLI
Appili Therapeutics Inc. |
Froehlich, Juergen
4 - Director of Issuer
Direct Ownership
|
Options
38 - Redemption, retraction, cancellation, repurchase
|
$-152,600
-140,000 vol $1.09 each |
385,000 | |
| Filed 2023-01-12 13:58 Tx date 2023-01-04 |
$APLI
Appili Therapeutics Inc. |
Froehlich, Juergen
4 - Director of Issuer
Direct Ownership
|
Options
38 - Redemption, retraction, cancellation, repurchase
|
$-114,800
-140,000 vol $0.82 each |
525,000 | |
| Filed 2021-12-13 14:02 Tx date 2021-12-08 |
$APLI
Appili Therapeutics Inc. |
Froehlich, Juergen
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$31,850
+245,000 vol $0.13 each |
665,000 | |
| Filed 2021-05-08 13:04 Tx date 2021-05-07 |
$APLI
Appili Therapeutics Inc. |
Froehlich, Juergen
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$170,800
+140,000 vol $1.22 each |
420,000 | |
| Filed 2020-09-18 19:45 Tx date 2020-09-16 |
$APLI
Appili Therapeutics Inc. |
Froehlich, Juergen
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$152,600
+140,000 vol $1.09 each |
280,000 | |
| Filed 2020-02-05 15:59 Tx date 2020-01-24 |
$APLI
Appili Therapeutics Inc. |
Froehlich, Juergen
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$114,099
+140,000 vol $0.81 each |
140,000 | |
| Filed 2020-02-05 15:55 Tx date 2020-01-24 |
$APLI
Appili Therapeutics Inc. |
Froehlich, Juergen
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|